Induction of hepatic CYP2B1/2 by a teratogenic compound cis-1-[-4-(P- menthane-8-yloxy)phenyl]piperadine (YM9429) in rats

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

A teratogenic compound cis-1-[-4-(p-menthane-8- yloxy)phenyl]piperadine(YM9429) selectively induces skeletal malformations characterized by cleft palate in rat fetuses. In the present study, we investigated the effect of YM9429 on hepatic cytochrome P-450s and their activities in rats. Oral administrations of YM9429 at a dose of 250, 500 or 750 mg/kg daily for 3 days induced cytochrome P-450 contents in a dose- dependent manner. Concomitant induction of enzyme activities of benzphetamine N-demethylase, erythromycin N-demethylase and, to a lesser extent, aminopyrine N-demethylase was observed. Immunoblot analysis revealed that YM9429 up-regulated hepatic levels of CYP2B1/2 and CYP3A1/2 proteins. A single dose of YM9429 at 250 mg/kg induced CYP2B1/2 protein levels significantly. These results suggest that YM9429 is a strong inducer of cytochrome P-450 with characteristics resembling those of phenobarbital.

Cite

CITATION STYLE

APA

Numazawa, S., Shibata, M., Imaoka, S., Funae, Y., & Yoshida, T. (2000). Induction of hepatic CYP2B1/2 by a teratogenic compound cis-1-[-4-(P- menthane-8-yloxy)phenyl]piperadine (YM9429) in rats. Journal of Toxicological Sciences, 25(1), 57–61. https://doi.org/10.2131/jts.25.57

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free